2014 -- S 2561

========

LC004106

========

     STATE OF RHODE ISLAND

IN GENERAL ASSEMBLY

JANUARY SESSION, A.D. 2014

____________

A N   A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT

     

     Introduced By: Senator Maryellen Goodwin

     Date Introduced: February 27, 2014

     Referred To: Senate Health & Human Services

     It is enacted by the General Assembly as follows:

1

     SECTION 1. Sections 21-28-3.11 and 21-28-3.18 of the General Laws in Chapter 21-28

2

entitled "Uniform Controlled Substances Act" are hereby amended to read as follows:

3

     21-28-3.11. Form, delivery, and preservation of official written orders. – (a) An

4

official written order for any controlled substance shall be signed in duplicate by the person

5

giving the order or by his or her duly authorized agent. The original shall be presented to the

6

person who sells or distributes the controlled substances named in it. In the event of the

7

acceptance of the order by that person, each party to the transaction shall preserve his or her copy

8

of the order for a period of two (2) years in such a way as to be readily accessible for inspection

9

by any public officer or employee engaged in the enforcement of this chapter. It shall be deemed

10

a compliance with this section if the parties to the transaction have complied with the federal law

11

respecting the requirements governing the use of order forms.

12

     (b) Nothing in this section shall be construed as prohibiting the person giving the order,

13

or his or her duly authorized agent, from presenting said order to the person who sells or

14

distributes the controlled substances named in it by use of facsimile transmission.

15

     21-28-3.18. Prescriptions. -- (a) An apothecary in good faith may sell and dispense

16

controlled substances in schedule II, III, IV and V to any person upon a valid prescription by a

17

practitioner licensed by law to prescribe or administer those substances, dated and signed by the

18

person prescribing on the day when issued and bearing the full name and address of the patient to

19

whom, or of the owner of the animal for which, the substance is dispensed and the full name,

 

1

address, and registration number under the federal law of the person prescribing, if he or she is

2

required by that law to be registered. If the prescription is for an animal, it shall state the species

3

of the animal for which the substance is prescribed.

4

      (b) When filling a hard-copy prescription for a schedule II controlled substance, the

5

apothecary filling the prescription shall sign his or her full name and shall write the date of filling

6

on the face of the prescription.

7

      (c) The prescription shall be retained on file by the proprietor of the pharmacy in which

8

it was filled for a period of two (2) years so as to be readily accessible for inspection by any

9

public officer or employee engaged in the enforcement of this chapter.

10

      (d) (1) Hard copy prescriptions for controlled substances in schedule II shall be filed

11

separately and shall not be refilled.

12

      (2) The director of health may shall, after appropriate notice and hearing pursuant to

13

section §42-35-3, promulgate rules and regulations for the purpose of adopting a system for

14

electronic data transmission, including by facsimile, of prescriptions for controlled substances in

15

schedule II, III and IV.

16

      (3) A practitioner may sign and transmit electronic prescriptions for controlled

17

substances and a pharmacy may dispense an electronically transmitted prescription in accordance

18

with the code of federal regulations, title 21 part 1300, et seq.

19

      (e) A prescription for a schedule II narcotic substance to be compounded for the direct

20

administration to a patient by parenteral, intravenous, intramuscular, subcutaneous, or intraspinal

21

infusion may be transmitted by the practitioner, or practitioner's agent, to the pharmacy by

22

facsimile. The facsimile will serve as the original prescription.

23

      (f) A prescription for a schedule II substance for a resident of a long term care facility

24

may be transmitted by the practitioner or the practitioner's agent to the dispensing pharmacy by

25

facsimile. The facsimile serves as the original prescription.

26

      (g) A prescription for a schedule II narcotic substance for a patient residing in a hospice

27

certified by Medicare under title XVIII of the Social Security Act, 42 U.S.C. section 1395 et seq.,

28

or licensed by the state, may be transmitted by the practitioner, or practitioner's agent, to the

29

dispensing pharmacy by facsimile. The practitioner, or the practitioner's agent, will note on the

30

prescription that the patient is a hospice patient. The facsimile serves as the original, written

31

prescription.

32

      (h) An apothecary, in lieu of a written prescription, may sell and dispense controlled

33

substances in schedules III, IV, and V to any person upon an oral prescription of a practitioner. In

34

issuing an oral prescription, the prescriber shall furnish the apothecary with the same information

 

LC004106 - Page 2 of 6

1

as is required by subsection (a) of this section and the apothecary who fills the prescription, shall

2

immediately reduce the oral prescription to writing and shall inscribe the information on the

3

written record of the prescription made. This record shall be filed and preserved by the proprietor

4

of the pharmacy in which it is filled in accordance with the provisions of subsection (c) of this

5

section. In no case may a prescription for a controlled substance listed in schedules III, IV, or V

6

be filled or refilled more than six (6) months after the date on which the prescription was issued

7

and no prescription shall be authorized to be refilled more than five (5) times. Each refilling shall

8

be entered on the face or back of the prescription and note the date and amount of controlled

9

substance dispensed, and the initials or identity of the dispensing apothecary.

10

      (i) In the case of an emergency situation as defined in federal law, an apothecary may

11

dispense a controlled substance listed in schedule II upon receiving an oral authorization of a

12

prescribing practitioner provided that:

13

      (1) The quantity prescribed and dispensed is limited to the amount adequate to treat the

14

patient during the emergency period and dispensing beyond the emergency period must be

15

pursuant to a written prescription signed by the prescribing practitioner.

16

      (2) The prescription shall be immediately reduced to writing and shall contain all the

17

information required in subsection (a) of this section.

18

      (3) The prescription must be dispensed in good faith in the normal course of professional

19

practice.

20

      (4) Within seven (7) days after authorizing an emergency oral prescription, the

21

prescribing practitioner shall cause a prescription for the emergency quantity prescribed to be

22

delivered to the dispensing apothecary. The prescription shall have written on its face

23

"Authorization for emergency dispensing" and the date of the oral order. The prescription upon

24

receipt by the apothecary, shall be attached to the oral emergency prescription which that had

25

earlier been reduced to writing.

26

      (j) (1) The partial filling of a prescription for a controlled substance listed in schedule II

27

is permissible, if the apothecary is unable to supply the full quantity called for in a prescription or

28

emergency oral prescription and he or she makes a notation of the quantity supplied on the face of

29

the prescription or oral emergency prescription which that has been reduced to writing. The

30

remaining portion of the prescription may be filled within seventy-two (72) hours of the first

31

partial filling, however, if the remaining portion is not, or cannot be, filled within seventy-two

32

(72) hours, the apothecary shall notify the prescribing practitioner. No further quantity may be

33

supplied beyond seventy-two (72) hours without a new prescription.

34

      (2) (i) A prescription for a schedule II controlled substance written for a patient in a

 

LC004106 - Page 3 of 6

1

long-term-care facility (LTCF), or for a patient with a medical diagnosis documenting a terminal

2

illness, may be filled in partial quantities to include individual dosage units. If there is a question

3

whether a patient may be classified as having a terminal illness, the pharmacist must contact the

4

practitioner prior to partially filling the prescription. Both the pharmacist and the prescribing

5

practitioner have a corresponding responsibility to assure that the controlled substance is for a

6

terminally ill patient.

7

      (ii) The pharmacist must record on the prescription whether the patient is "terminally ill"

8

or an "LTCF patient." A prescription that is partially filled, and does not contain the notation

9

"terminally ill" or "LTCF patient", shall be deemed to have been filled in violation of this chapter.

10

      (iii) For each partial filling, the dispensing pharmacist shall record on the back of the

11

prescription (or on another appropriate record, uniformly maintained, and readily retrievable),

12

the:

13

      (A) Date of the partial filling;

14

      (B) Quantity dispensed;

15

      (C) Remaining quantity authorized to be dispensed; and

16

      (D) Identification of the dispensing pharmacist.

17

      (iv) The total quantity of schedule II controlled substances dispensed in all partial fillings

18

must not exceed the total quantity prescribed.

19

      (v) Schedule II prescriptions for patients in a LTCF, or patients with a medical diagnosis

20

documenting a terminal illness, are valid for a period not to exceed sixty (60) days from the issue

21

date, unless sooner terminated by the discontinuance of medication.

22

      (k) Automated data processing systems. - As an alternative to the prescription record

23

keeping provision of subsection (h) of this section, an automated data processing system may be

24

employed for the record keeping system, if the following conditions have been met:

25

      (1) The system shall have the capability of producing sight-readable documents of all

26

original and refilled prescription information. The term "sight-readable" means that an authorized

27

agent shall be able to examine the record and read the information. During the course of an on-

28

site inspection, the record may be read from the CRT, microfiche, microfilm, printout, or other

29

method acceptable to the director. In the case of administrative proceedings, records must be

30

provided in a paper printout form.

31

      (2) The information shall include, but not be limited to, the prescription requirements

32

and records of dispensing as indicated in subsection (h) of this section.

33

      (3) The individual pharmacist responsible for completeness and accuracy of the entries

34

to the system must provide documentation of the fact that prescription information entered into

 

LC004106 - Page 4 of 6

1

the computer is correct. In documenting this information, the pharmacy shall have the option to

2

either:

3

      (i) Maintain a bound log book, or separate file, in which each individual pharmacist

4

involved in the dispensing shall sign a statement each day, attesting to the fact that the

5

prescription information entered into the computer that day has been reviewed and is correct as

6

shown. The book or file must be maintained at the pharmacy employing that system for a period

7

of at least two (2) years after the date of last dispensing; or

8

      (ii) Provide a printout of each day's prescription information. That printout shall be

9

verified, dated, and signed by the individual pharmacist verifying that the information indicated is

10

correct. The printout must be maintained at least two (2) years from the date of last dispensing.

11

      (4) An auxiliary record keeping system shall be established for the documentation of

12

refills, if the automated, data-processing system is inoperative for any reason. The auxiliary

13

system shall ensure that all refills are authorized by the original prescription, and that the

14

maximum number of refills is not exceeded. When this automated data processing system is

15

restored to operation, the information regarding prescriptions filled and refilled during the

16

inoperative period, shall be entered into the automated, data processing system within ninety-six

17

(96) hours.

18

      (5) Any pharmacy using an automated, data processing system must comply with all

19

applicable state and federal laws and regulations.

20

      (6) A pharmacy shall make arrangements with the supplier of data processing services or

21

materials to ensure that the pharmacy continues to have adequate and complete prescription and

22

dispensing records if the relationship with the supplier terminates for any reason. A pharmacy

23

shall ensure continuity in the maintenance of records.

24

      (7) The automated, data-processing system shall contain adequate safeguards for security

25

of the records, to maintain the confidentiality and accuracy of the prescription information.

26

Safeguards against unauthorized changes in data after the information has been entered and

27

verified by the registered pharmacist shall be provided by the system.

28

      (l) Prescriptions for controlled substances as found in schedules II, will become void

29

unless dispensed within ninety (90) days of the original date of the prescription, and in no event

30

shall more than a thirty (30) day (30) supply be dispensed at any one time.

31

      (1) In prescribing controlled substances in schedule II, practitioners may write up to

32

three (3), separate prescriptions, each for up to a one-month supply, each signed and dated on the

33

date written. For those prescriptions for the second and/or third month, the practitioner must write

34

the earliest date each of those subsequent prescription may be filled, with directions to the

 

LC004106 - Page 5 of 6

1

pharmacist to fill no earlier than the date specified on the face of the prescription.

2

      (m) The prescriptions in schedules III, IV, and V will become void unless dispensed

3

within one hundred eighty (180) days of the original date of the prescription. For purposes of this

4

section, a "dosage unit" shall be defined as a single capsule, tablet, or suppository, or not more

5

than one five (5) ml. of an oral liquid.

6

      (1) Prescriptions in Schedule III cannot be written for more than one hundred (100)

7

dosage units and not more than one hundred (100) dosage units may be dispensed at one time.

8

      (2) Prescriptions in Schedule IV and V may be written for up to a ninety (90) day (90)

9

supply based on directions. No more than three hundred and sixty (360) dosage units may be

10

dispensed at one time.

11

     SECTION 2. This act shall take effect upon passage.

========

LC004106

========

 

LC004106 - Page 6 of 6

EXPLANATION

BY THE LEGISLATIVE COUNCIL

OF

A N   A C T

RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT

***

1

     This act would require, rather than permit, the director of health to promulgate rules and

2

regulations for the purpose of adopting a system for electronic data transmission, including by

3

facsimile, of prescriptions for controlled substances in schedules II, III and IV.

4

     This act would take effect upon passage.

========

LC004106

========

 

LC004106 - Page 7 of 6